Neurogene (NGNE) Current Leases (2018 - 2026)
Neurogene (NGNE) recorded Current Leases of $5,000 in Q2 2026, down 88.1% from $42,000 a year earlier and down 44.4% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Current Leases (2018 - 2026) Analysis & Trends
At the end of FY2025, Neurogene reported Current Leases of $14,000, down 74.1% from FY2024.
- Annual Current Leases has a five-year compound annual growth rate of -22.2% (FY2020 to FY2025).
- Across earlier years, Current Leases came in at $54,000 in FY2024 (+28.6%), $42,000 in FY2023 (+75.0%), $24,000 in FY2022 (-56.4%) and $55,000 in FY2021 (+12.2%).
- The Q2 2026 figure is the lowest quarterly Current Leases since Q3 2023.
- On a year-over-year basis, Current Leases has declined for five consecutive quarters, with an average decline of 37.9% over the last seven quarters.
- Peak year-over-year performance for Current Leases in the last five years was growth of 452.7% in Q1 2023, against a decline of 97.5% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $9,000 (Q1 2026), $14,000 (Q4 2025) and $31,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Neurogene | 586.35 Mn | -416.64 Mn | - | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 304,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 59,000.00 |
| Jun 30, 2022 | 118,000.00 |
| Mar 31, 2022 | 55,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 104,000.00 |
API Access
Neurogene Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();